Status:

COMPLETED

Comparison of Efficacy and Safety of Two Biphasic Defibrillators in Cardioversion of Atrial Fibrillation

Lead Sponsor:

University National Heart Hospital

Conditions:

Atrial Fibrillation

Arrythmia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Background: Biphasic truncated exponential (BTE) waveforms are standard for cardiac defibrillation and synchronized cardioversion up to date. BTE waveforms differ by design characteristics and technol...

Detailed Description

Background: External defibrillators are routinely used for treatment of lethal ventricular arrhythmias (defibrillation) as well as atrial and non-lethal ventricular arrhythmias (synchronized CVS). Co...

Eligibility Criteria

Inclusion

  • (indications for elective cardioversion of atrial fibrillation):
  • Patients \> 18 years old and:
  • Symptomatic AFIB with a duration of less than 12 months - EHRA score 2-4
  • Symptomatic first detected AFIB - EHRA score 2-4
  • Persistent AFIB after successful causal therapy

Exclusion

  • The patients are excluded if one of these conditions is present:
  • Patients with atrial flutter
  • Spontaneous HR \<60/min
  • Digitalis intoxication
  • Impossibility to maintain sinus rhythm irrespective to antiarrhythmic therapy and frequent cardioversions
  • Conduction disturbances (without fascicular block and AV block 1 degree) in patients without pacemaker
  • Asymptomatic patients with AFIB for \> 1 year
  • Thyroid dysfunction: euthyroid status of at least one month is required (TSH is measured).
  • Thrombosis in cardiac cavities, assessment performed using Transesophageal echocardiography (TEE)
  • Spontaneous echo contrast \> 2 degree (TEE)
  • Patients with planned cardiac operation in the next three months
  • Patients with embolic event in the last three months
  • Patients \<18 years of age
  • Pregnancy

Key Trial Info

Start Date :

February 5 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 6 2020

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT04032678

Start Date

February 5 2019

End Date

August 6 2020

Last Update

August 25 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University National Heart Hospital

Sofia, Bulgaria, 1309